Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging Concepts and Human Trials in Alpha-1-Antitrypsin Deficiency Liver Disease.

Seminars in liver disease - 1 May 2017

Teckman Jeffrey H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Therapy
Share to alpha 1-Antitrypsin
Share to alpha 1-Antitrypsin Deficiency
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme Replacement Therapy

Share to Gene Expression Regulation, Enzymologic

Share to Liver Cirrhosis

Share to Molecular Targeted Therapy

Source

Identifiers

PMID: 28564723
DOI: 10.1055/s-0037-1602586

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging Concepts and Human Trials in Alpha-1-Antitrypsin Deficiency Liver Disease.PMID 28564723Read ↗

Alpha-1-Antitrypsin Deficiency Liver DiseaseSemantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency Liver DiseaseSemantic proximity Read ↗

Pathogenesis of alpha 1-antitrypsin deficiency-associated liver disease, 1990.Semantic proximity Read ↗

Clinical manifestations of alpha 1-antitrypsin deficiency.Semantic proximity Read ↗

The future of hepatology.Semantic proximity Read ↗

Current status of alpha-1-antitrypsin replacement therapy: recommendations for the management of patients with severe hereditary deficiency. Ad Hoc Committee on Alpha-1-Antitrypsin Replacement Therapy of the Standards Committee, Canadian Thoracic Society.Semantic proximity Read ↗

[alpha 1-antitrypsin deficiency and liver diseases].Semantic proximity Read ↗

Is severe progressive liver disease caused by alpha-1-antitrypsin deficiency more common in children or adults?Semantic proximity Read ↗

Focus on hepatitis. Final APRICOT, ACTG A5071 results.Semantic proximity Read ↗

Alpha1-antitrypsin deficiency: New therapies on the horizon.Semantic proximity Read ↗

The 21st century hepatologist and a systems biology based approach to liver diseases.Semantic proximity Read ↗

Pathogenesis of liver disease in alpha 1-antitrypsin deficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.